Literature DB >> 518680

The interaction of benzimidazole carbamates with mammalian microtobule protein.

C M Ireland, K Gull, W E Gutteridge, C I Pogson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 518680     DOI： 10.1016/0006-2952(79)90049-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  17 in total

1.  Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro.

Authors:  R J Vasquez; B Howell; A M Yvon; P Wadsworth; L Cassimeris
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

2.  Population Pharmacokinetic Model of Oxfendazole and Metabolites in Healthy Adults following Single Ascending Doses.

Authors:  Thanh Bach; Daryl J Murry; Larissa V Stebounova; Gregory Deye; Patricia Winokur; Guohua An
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

3.  Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme.

Authors:  Ren-Yuan Bai; Verena Staedtke; Colette M Aprhys; Gary L Gallia; Gregory J Riggins
Journal:  Neuro Oncol       Date:  2011-07-15       Impact factor: 12.300

4.  Genetic effects of methyl benzimidazole-2-yl-carbamate on Saccharomyces cerevisiae.

Authors:  J S Wood
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

5.  Influence of the antimicrotubule agent, mebendazole, on the secretory activity of intestinal cells of Ascaridia galli.

Authors:  C Atkinson; R J Newsam; K Gull
Journal:  Protoplasma       Date:  1980       Impact factor: 3.356

6.  Biological Evaluation of a Potential Anticancer Agent Methyl N-[5-(3'-Iodobenzoyl)-1H-Benzimidazol-2-yl]Carbamate.

Authors:  Zbigniew P Kortylewicz; Don W Coulter; Janina Baranowska-Kortylewicz
Journal:  Cancer Biother Radiopharm       Date:  2019-11-05       Impact factor: 3.099

7.  Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines.

Authors:  S Rolin; H Souhaili-el Amri; A M Batt; M Levy; D Bagrel; G Siest
Journal:  Cell Biol Toxicol       Date:  1989-01       Impact factor: 6.691

8.  Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642).

Authors:  Desirée Hao; Jinee D Rizzo; Stephanie Stringer; Rodney V Moore; Jennifer Marty; Daniel L Dexter; Gina L Mangold; James B Camden; Daniel D Von Hoff; Steven D Weitman
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

9.  Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

Authors:  A W Stitt; I Fairweather
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

10.  Rearrangement of microtubule network under biochemical and mechanical stimulations.

Authors:  Emrah Celik; Midhat H Abdulreda; Dony Maiguel; Jie Li; Vincent T Moy
Journal:  Methods       Date:  2013-03-04       Impact factor: 3.608
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.